Adult isolated intestinal and multivisceral transplantation is gaining acceptance as the standard treatment for patients with intestinal failure with life-threatening parenteral nutrition-related complications. We report our 4-year experience with intestinal and multivisceral transplantation. We performed 20 isolated small bowel and seven multivisceral ones, including three with liver. The underlying diseases were mainly short bowel syndrome due to intestinal infarction, chronic intestinal pseudo-obstruction, and Gardner syndrome. Indications for transplant were loss of central venous access in 14 patients, recurrent sepsis in eight patients, and major electrolyte and fluid imbalance in five patients. One-year patient actuarial survival rate was 94% for isolated intestinal transplants and 42% for multivisceral recipients (P =.003), while 1-year graft actuarial survival rate was 88.4% for isolated small bowel patients and 42.8% for multivisceral ones (P =.01). The death rate was 18.5%. Our graftectomy rate was 14.8%. Our immunosuppressive protocols were based on induction agents such as alemtuzumab, daclizumab, and antithymocyte globulins. The majority of our complications were bacterial infections, followed by rejections and relaparotomies; most rejection episodes were treated with steroid boluses and tapering. We believe that our results were due to optimal candidate and donor selection, short ischemia time, and use of induction therapy. Multivisceral transplantation is a more complex procedure with less frequent clinical indications than isolated small bowel transplant, but our data concerning multivisceral transplants include only a small number of patients and require further evaluation.

Twenty-seven consecutive intestinal and multivisceral transplants in adult patients: a 4-year clinical experience / A., Lauro; DI BENEDETTO, Fabrizio; Masetti, Michele; Cautero, Nicola; G., Ercolani; M., Vivarelli; N., De Ruvo; M., Cescon; G., Varotti; A., Dazzi; A., Siniscalchi; Begliomini, Bruno; L., Pironi; M., Di Simone; A., D'Errico; G., Ramacciato; G., Grazi; A. D., Pinna. - In: TRANSPLANTATION PROCEEDINGS. - ISSN 0041-1345. - STAMPA. - 37:6(2005), pp. 2679-2681. [10.1016/j.transproceed.2005.06.071]

Twenty-seven consecutive intestinal and multivisceral transplants in adult patients: a 4-year clinical experience.

DI BENEDETTO, Fabrizio;MASETTI, Michele;CAUTERO, Nicola;BEGLIOMINI, Bruno;
2005

Abstract

Adult isolated intestinal and multivisceral transplantation is gaining acceptance as the standard treatment for patients with intestinal failure with life-threatening parenteral nutrition-related complications. We report our 4-year experience with intestinal and multivisceral transplantation. We performed 20 isolated small bowel and seven multivisceral ones, including three with liver. The underlying diseases were mainly short bowel syndrome due to intestinal infarction, chronic intestinal pseudo-obstruction, and Gardner syndrome. Indications for transplant were loss of central venous access in 14 patients, recurrent sepsis in eight patients, and major electrolyte and fluid imbalance in five patients. One-year patient actuarial survival rate was 94% for isolated intestinal transplants and 42% for multivisceral recipients (P =.003), while 1-year graft actuarial survival rate was 88.4% for isolated small bowel patients and 42.8% for multivisceral ones (P =.01). The death rate was 18.5%. Our graftectomy rate was 14.8%. Our immunosuppressive protocols were based on induction agents such as alemtuzumab, daclizumab, and antithymocyte globulins. The majority of our complications were bacterial infections, followed by rejections and relaparotomies; most rejection episodes were treated with steroid boluses and tapering. We believe that our results were due to optimal candidate and donor selection, short ischemia time, and use of induction therapy. Multivisceral transplantation is a more complex procedure with less frequent clinical indications than isolated small bowel transplant, but our data concerning multivisceral transplants include only a small number of patients and require further evaluation.
2005
37
6
2679
2681
Twenty-seven consecutive intestinal and multivisceral transplants in adult patients: a 4-year clinical experience / A., Lauro; DI BENEDETTO, Fabrizio; Masetti, Michele; Cautero, Nicola; G., Ercolani; M., Vivarelli; N., De Ruvo; M., Cescon; G., Varotti; A., Dazzi; A., Siniscalchi; Begliomini, Bruno; L., Pironi; M., Di Simone; A., D'Errico; G., Ramacciato; G., Grazi; A. D., Pinna. - In: TRANSPLANTATION PROCEEDINGS. - ISSN 0041-1345. - STAMPA. - 37:6(2005), pp. 2679-2681. [10.1016/j.transproceed.2005.06.071]
A., Lauro; DI BENEDETTO, Fabrizio; Masetti, Michele; Cautero, Nicola; G., Ercolani; M., Vivarelli; N., De Ruvo; M., Cescon; G., Varotti; A., Dazzi; A., Siniscalchi; Begliomini, Bruno; L., Pironi; M., Di Simone; A., D'Errico; G., Ramacciato; G., Grazi; A. D., Pinna
File in questo prodotto:
File Dimensione Formato  
Twenty-Seven Consecutive Intestinal and Multivisceral Transplants in Adult Patients- A 4-Year Clinical Experience.pdf

Solo gestori archivio

Tipologia: Versione pubblicata dall'editore
Dimensione 50.98 kB
Formato Adobe PDF
50.98 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/310306
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 10
social impact